Quince Therapeutics
QNCX
#9472
Rank
โ‚ฌ47.19 M
Marketcap
1,07ย โ‚ฌ
Share price
8.26%
Change (1 day)
7.97%
Change (1 year)

EPS for Quince Therapeutics (QNCX)

EPS in 2023 (TTM): -0,79ย โ‚ฌ

According to Quince Therapeutics's latest financial reports the company's current EPS (TTM) is -0,73ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -1,39ย โ‚ฌ an increase over its 2021 EPS that were of -2,66ย โ‚ฌ.

EPS history for Quince Therapeutics from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,79ย โ‚ฌ-43.41%
2022-1,39ย โ‚ฌ-47.85%
2021-2,66ย โ‚ฌ15.21%
2020-2,31ย โ‚ฌ62.51%
2019-1,42ย โ‚ฌ179.56%
2018-0,51ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-1,92ย โ‚ฌ 162.65%๐Ÿ‡บ๐Ÿ‡ธ USA